Related Experiment Video
Updated: May 9, 2026
05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
Recent progress of genome study for anaplastic thyroid cancer
Jieun Lee1, Jung-Ah Hwang, Eun Kyung Lee
1Cancer Genomics Branch, Research Institute, National Cancer Center, Goyang 410-769, Korea.
Genomics & Informatics
|July 12, 2013
Summary
Anaplastic thyroid cancer (ATC) is a deadly cancer with poor prognosis and treatment resistance. Genomic research is crucial for understanding and treating this aggressive disease.
Area of Science:
- Oncology
- Genetics
- Genomics
Background:
- Anaplastic thyroid cancer (ATC) is a highly aggressive malignancy with a very poor prognosis.
- ATC exhibits significant resistance to current cancer treatments, necessitating novel therapeutic strategies.
- The role of genomic alterations in ATC tumorigenesis remains largely undefined.
Purpose of the Study:
- To review comprehensive genetic alterations in ATC.
- To explore recent approaches for identifying genomic alterations in ATC.
- To highlight the urgent need for genomic research in ATC.
Main Methods:
- Literature review of genome-wide studies in ATC.
- Analysis of published reports on genetic alterations in ATC.
- Synthesis of current knowledge on ATC genomics.
Main Results:
- Few genome-wide studies have been published on ATC.
- Understanding genomic alterations is critical for developing targeted therapies.
- Current knowledge on ATC genomic landscape is limited.
Conclusions:
- There is an urgent need for extensive genomic research in anaplastic thyroid cancer.
- Genomic insights are essential for improving prevention and treatment strategies for ATC.
- Further investigation into ATC's genetic landscape may reveal novel therapeutic targets.
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...